Ultrasis (LSE:ULT) Research & Development: £0.00 Mil (TTM As of Jul. 2014)


What is Ultrasis Research & Development?

Ultrasis LSE:ULT Research & Development is £0.00 Mil as of Jul. 2014. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Ultrasis's Research & Development for the six months ended in Jul. 2014 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jul. 2014 was £0.00 Mil.

Ultrasis  (LSE:ULT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ultrasis Research & Development Related Terms

Ultrasis Research & Development Historical Data

* Premium members only.

The historical data trend for Ultrasis's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ultrasis Research & Development Chart

Ultrasis Annual Data
Trend Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ultrasis Semi-Annual Data
Jul96 Jul97 Jul98 Jul99 Jul00 Jul01 Jul02 Jul03 Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ultrasis Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Jul. 2014 was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.00 Mil mean?
Ultrasis (LSE:ULT) has a Research & Development of £0.00 Mil as of Jul. 2014. Research and development expense is the total cost for research and development activities. View historical data on Ultrasis and its competitors.
Is Ultrasis' Research & Development too high?
Ultrasis' current Research & Development is £0.00 Mil.
How does Ultrasis' Research & Development compare to competitors?
Ultrasis' Research & Development of £0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ultrasis and its competitors. Ultrasis's current Research & Development is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultrasis stock overvalued right now?
Ultrasis (LSE:ULT) has a current Research & Development of £0.00 Mil. The current Research & Development is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ultrasis (LSE:ULT), the current Research & Development is £0.00 Mil as of Jul. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ultrasis Business Description

Ultrasis PLC was incorporated in November 23, 1981. The Company through its subsidiary provides healthcare products and services provided via the medium of technology or face to face, that help people maintain, regain and improve their physical, psychological and social well-being. Its product includes Beating the Blues(r), GetFit Wellness, My Brain Solutions, The Relief Series, Drink & Drug Wise, Calm Workplace, and Optimise Me, Screenetics and Joggle.